Advertisement

Archives of Toxicology

, Volume 68, Issue 10, pp 648–655 | Cite as

In vitro oxime-induced reactivation of various molecular forms of soman-inhibited acetylcholinesterase in striated muscle from rat, monkey and human

  • John G. Clement
  • Nancy Erhardt
Article

Abstract

The purpose of this study was to compare the in vitro reactivation of the various molecular forms of soman-inhibited acetylcholinesterase by oximes such as HI-6, toxogonin and PAM, in striated muscle tissue from three species-rat, monkey and human. To simulate the various in vivo conditions the oxime was present either 5 min before and after (Pre-Post) or 5 min after (Post) exposure to the nerve agent soman. In the Pre-Post mode the oxime effects would result from a combination of not only shielding of acetylcholinesterase from soman inhibition but also from immediate reactivation of soman-inhibited acetylcholinesterase. In the Post experimental group the increase in soman-inhibited acetylcholinesterase activity was due to reactivation. HI-6 (Pre-Post) increased significantly the activity of soman-inhibited acetylcholinesterase in the rat, human and monkey muscle. HI-6 (Post) was a highly effective reactivator of soman-inhibited acetylcholinesterase in the rat muscle and moderately so in the human and monkey muscle. Toxogonin (Pre-Post) and toxogonin (Post) were effective in increasing soman-inhibited acetylcholinesterase activity in rat muscle but were relatively ineffective in the human and monkey muscle. PAM (Pre-Post) and PAM (Post) were ineffective in increasing soman-inhibited acetylcholinesterase activity in muscle from all species examined. Effectiveness of oxime-induced reactivation of soman-inhibited acetylcholinesterase could be estimated from the total acetylcholinesterase activity which appears to reflect the results found with the individual molecular forms of acetylcholinesterase. In addition, SAD-128, a non-oxime bispyridinium compound, appeared to enhance significantly the HI-6 induced reactivation of soman-inhibited acetylcholinesterase in human but not rat striated muscle.

Key words

Oxime Soman Acetylcholinesterase Striated muscle Rat Human Monkey 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Berends F (1987) Mechanisms of ageing of organophosphate-inhibited esterases. In: De Matteis F, Lock EA (eds) Structure molecular mechanisms toxicity, McMillan Press, UK, pp 125–152Google Scholar
  2. Boskovic B (1981) The treatment of soman poisoning and its perspectives. Fundam Appl Toxicol 1: 203–213CrossRefPubMedGoogle Scholar
  3. Clement JG (1979) Efficacy of PRO-PAM (Af-methyl-l,6-dihydropyridine-2-carbaldoxime hydrochloride) as a prophylaxis against organophosphate poisoning. Toxicol Appl Pharmacol 47: 305–311CrossRefPubMedGoogle Scholar
  4. Clement JG (1981) Toxicology and pharmacology of bispyridinium oximes — insight into the mechanism of action vs soman poisoning in vivo. Fundam Appl Toxicol 1: s193-s202CrossRefGoogle Scholar
  5. Clement JG (1983) Efficacy of mono- and bis-pyridinium oximes versus soman, sarin and tabun poisoning in mice. Fundam Appl Toxicol 3: 533–535CrossRefPubMedGoogle Scholar
  6. Clement JG (1991) Variability of sarin-induced hypothermia in mice: investigation into incidence and mechanism. Biochem Pharmacol 42: 1316–1318CrossRefPubMedGoogle Scholar
  7. Clement JG, Lee MJ, Simons KJ, Briggs CJ (1990) Pharmacokinetics of the acetylcholinesterase oxime reactivator, HI-6, in rhesus monkeys (Macaca mulatto): effect of atropine, diazepam and methoxyflurane anesthesia. Biopharm Drug Dispos 11: 227–232CrossRefPubMedGoogle Scholar
  8. Clement JG, Pierce CH, Houle J-M (1992) Ascending dose tolerance study of the oxime, HI-6, in man. Proc 4th International Symposium, Protection Against Chemical Warfare Agents, June 8-12, 1992 Stockholm, SwedenGoogle Scholar
  9. Clement JG, Madill HD, Bailey DG, Spence JD (1993) Clinical study of a new therapy for nerve agent poisoning: ascending dose tolerance study of HI-6 + atropine in man. United States Army 1993 Medical Defense Bioscience Review. May 10-13,1993 Baltimore, Md.Google Scholar
  10. Clement JG, Rosario S, Bessette E, Erhardt N (1991) Soman and sarin inhibition of molecular forms of acetylcholinesterase in mice: time course of recovery and reactivation by the oxime HI-6. Biochem Pharmacol 42: 329–335CrossRefPubMedGoogle Scholar
  11. DeJong LPA, Wolring GZ (1980) Reactivation of acetylcholinesterase inhibited by l,2,2'-trimethylpropyl methylphosphonofluoridate (soman) with HI-6 and related oximes. Biochem Pharmacol 29: 2379–2387CrossRefGoogle Scholar
  12. DeJong LPA, Wolring GZ (1984) Stereospecific reactivation by some Hagedorn-oximes of acetylcholinesterases from various species including man, inhibited by soman. Biochem Pharmacol 33: 1119–1125CrossRefGoogle Scholar
  13. Ellman GL, Courtney KD, Andres V, Featherstone RM (1961) A new and rapid colorimetric determination of acetylcholinesterase activity. Biochem Pharmacol 7: 88–95CrossRefPubMedGoogle Scholar
  14. Ferguson G (1971) Statistical analysis in psychology and education, McGraw-Hill, New YorkGoogle Scholar
  15. Grubic Z, Tomazic A (1989) Mechanism of action of HI-6 on soman inhibition of acetylcholinesterase in preparations of rat and human skeletal muscle; comparison to SAD-128 and PAM-2. Arch Toxicol 63: 68–71CrossRefPubMedGoogle Scholar
  16. Hamilton MG, Lundy PM (1989) HI-6 therapy of soman and tabun poisoning in primates and rodents. Arch Toxicol 63: 144–149CrossRefPubMedGoogle Scholar
  17. Harris LW, Heyl WC, Stitcher DL, Broomfield CA (1978) Effects of 1,1-oxydimethylene bis-(4-tert-butylpyridinium chloride) (SAD-128) and decamethonium on reactivation of soman and sarin-inhibited Cholinesterase by oximes. Biochem Pharmacol 27: 757–761CrossRefPubMedGoogle Scholar
  18. Heffron PF, Hobbiger F (1979) Relationship between inhibition of acetylcholinesterase and response of the rat phrenic nerve-diaphragm preparation to indirect stimulation at higher frequencies. Br J Pharmacol 66: 323–329PubMedGoogle Scholar
  19. Inestrosa NC, Perelman A (1989) Distribution and anchoring of molecular forms of acetylcholinesterase. Trends Pharmacol Sei 10: 325–329CrossRefGoogle Scholar
  20. Koelle GB, Gilman A (1946) The chronic toxicity of di-isopropyl fluorophosphate (DFP) in dogs, monkeys and rats. J Pharmacol Exp Ther 87: 435–448PubMedGoogle Scholar
  21. Kusic R, Boskovic B, Vqjvodic V, Jovanovic D (1985) HI-6 in man: blood levels, urinary excretion and tolerance after intramuscular administration of the oxime to healthy volunteers. Fundam Appl Toxicol 5: S89-S97CrossRefPubMedGoogle Scholar
  22. Lipp J, Dola T (1980) Comparison of the efficacy of HS-6 versus HI-6 when combined atropine, pyridostigmine and clonazepam for soman poisoning in the monkey. Arch Int Pharmacodyn Ther 246: 138–148PubMedGoogle Scholar
  23. Lomax P, Kokka N, Lee R (1986) Acetylcholinesterase inhibitors and thermoregulation. In: Cooper K, Lomax P, Schonbaum G (eds) Homeostasis thermal stress. 6th International Symposium, Karger, Basel, pp 108–112Google Scholar
  24. Massoulie J, Bon S (1982) The molecular forms of Cholinesterase and acetylcholinesterase in vertebrates. Annu Rev Neurobiol 5: 57–106CrossRefGoogle Scholar
  25. Meeter E, Wolthuis OL (1968) The spontaneous recovery of respiration and neuromuscular transmission in the rat after anticholinesterase poisoning. Eur J Pharmacol 2: 377–386CrossRefPubMedGoogle Scholar
  26. Puu G, Artursson E, Bucht G (1986) Reactivation of nerve agent inhibited human acetylcholinesterases by HI-6 and obidoxime. Biochem Pharmacol 35: 1505–1510CrossRefPubMedGoogle Scholar
  27. Schoene K (1978) Aging of soman-inhibited acetylcholinesterase: inhibitors and accelerators. Biochim Biophys Acta 525: 468–471PubMedGoogle Scholar
  28. Shih TM (1993) Comparison of several oximes on reactivation of soman-inhibited blood, brain and tissue Cholinesterase activity in rats. Arch Toxicol 67: 637–646CrossRefPubMedGoogle Scholar
  29. Stale A, Sentjurc M (1990) A contribution to the mechanism of action of SAD-128. Biochem Pharmacol 40: 2511–2517CrossRefGoogle Scholar
  30. Tattersall JEH (1993) Ion channel blockade by oximes and recovery of diaphragm muscle from soman poisoning in vitro. Br J Pharmacol 108: 1006–1015PubMedGoogle Scholar
  31. Van Helden HPM, Van der Weil HJ, DeLange J, Busker RW, MelchersBPC, Wolthuis OL (1992) Therapeutic efficacy of HI-6 in soman poisoned marmoset monkeys. Toxicol Appl Pharmacol 115: 50–56CrossRefPubMedGoogle Scholar
  32. Wolthuis OL, Kepner LA (1978) Successful oxime therapy one hour after soman intoxication in the rat. Eur J Pharmacol 49: 415–425CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 1994

Authors and Affiliations

  • John G. Clement
    • 1
  • Nancy Erhardt
    • 1
  1. 1.Biomedical Defence SectionDefence Research Establishment SuffieldRalstonCanada

Personalised recommendations